The DOI matches its Crossref record; 78 of the 79 references it cites were found in a registry or an index.
Dystonia in Parkinson’s disease
Abstract
Dystonia can occasionally be found in idiopathic Parkinson's disease. It is very uncommon in untreated patients and is more frequently seen as a complication of its treatment. In this review, the various types of dystonia occurring in PD, the differential diagnosis with other parkinsonian syndromes associated with dystonia and treatments available are revised. Dystonia unrelated to treatment can be typical (blepharospasm, torticollis), atypical (parkinsonian writer's cramp, camptocormia, anismus), or occurring in earlyonset Parkinson disease (the so-called kinesigenic foot dystonia, considered a hallmark of early-onset Parkinson's disease). Early and prominent dystonia in untreated patients with parkinsonism should raise the suspicion of other entities other than Parkinson's disease, such as progressive supranuclear palsy, multiple system atrophy or corticobasal degeneration. In patients on chronic dopaminergic treatment, peak-dose dystonia, diphasic dystonia and off-dystonia can be seen. The later constitutes the major dystonic feature of chronic levodopa therapy, and a wide variety of strategies are available to manage this complication. Among them, deep brain stimulation of the subthalamic nucleus has proved to be the most effective one. Dystonic reactions (mainly involving oculomotor cranial nerves and limbs) in operated patients (especially carriers of deep brain stimulation (DBS) devices) are increasingly being reported, constituting a new type of dystonia in patients with Parkinson's disease: dystonia linked to surgical treatment.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The typical prediagnostic dystonias include unilateral equinovarus foot position, upper arm-forearm or forearmhand flexion, writer's cramp, oro-mandibular dystonia, torticollis or different combinations of these symptoms (Tolosa and Compta 2006).”
From The clinical symptoms of Parkinson's disease. (2016) · cites this paper as Tolosa and Compta 2006
In the citing paper
“In medically treated PD, dystonia, along with dyskinesias, constitutes one of the main motor complications related to chronic therapy, usually occurring as an off-period phenomenon, but can present as peak dose dystonia or diphasic dystonia (Tolosa and Compta 2006).”
From The clinical symptoms of Parkinson's disease. (2016) · cites this paper as Tolosa and Compta 2006
In the citing paper
“This may rarely be a prediagnostic symptom in PD (Tolosa and Compta 2006)”
From The clinical symptoms of Parkinson's disease. (2016) · cites this paper as Tolosa and Compta 2006
In the citing paper
“In young onset familial PD, dystonia typically involves the foot with cramp-like discomfort or inversion of the affected foot (Tolosa and Compta 2006).”
From The clinical symptoms of Parkinson's disease. (2016) · cites this paper as Tolosa and Compta 2006
In the citing paper
“In the majority of cases, the PD symptoms appear within 10 years from onset of the dystonia.”
From The clinical symptoms of Parkinson's disease. (2016) · cites this paper as Tolosa and Compta 2006
Citations
Cites
Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism
Kitada, T., Asakawa, S., Hattori, N., Matsumine, H., Yamamura, Y., Minoshima, S., Yokochi, M., Mizuno, Y., & Shimizu, N. (1998) · Nature · doi:10.1038/33416 · Cited by 5,227
Hereditary Early-Onset Parkinson's Disease Caused by Mutations in PINK1
Valente, E. M., Abou-Sleiman, P. M., Caputo, V., Muqit, M. M. K., Harvey, K., Gispert, S., Ali, Z., Del Turco, D., Bentivoglio, A. R., Healy, D. G., et al. (2004) · Science · doi:10.1126/science.1096284 · Cited by 3,481
Mutations in the DJ-1 Gene Associated with Autosomal Recessive Early-Onset Parkinsonism
Bonifati, V., Rizzu, P., van Baren, M. J., Schaap, O., Breedveld, G. J., Krieger, E., Dekker, M. C. J., Squitieri, F., Ibáñez, P., Joosse, M., et al. (2003) · Science · doi:10.1126/science.1077209 · Cited by 2,854
Neurodegenerative Disorders: Parkinson's Disease and Huntington's Disease
Hague, S., Klaffke, S., & Bandmann, O. (2006) · IMPERIAL COLLEGE PRESS eBooks · doi:10.1142/9781860948961_0007 · Cited by 2,767
Krack, P., Batir, A., Blercom, N. V., Chabardès, S., Fraix, V., Ardouin, C., Koudsié, A., Limousin, P., Benazzouz, A., LeBas, J., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa035275 · Cited by 2,208
Electrical stimulation of the subthalamic nucleus in advanced Parkinson's disease.
Limousin, P., Krack, P., Pollak, P., Benazzouz, A., Ardouin, C., Hoffmann, D., & Benabid, A. (1998) · New England Journal of Medicine · doi:10.1056/nejm199810153391603 · Cited by 2,030
Association between Early-Onset Parkinson's Disease and Mutations in theParkinGene
Lücking, C. B., Dürr, A., Bonifati, V., Vaughan, J. R., Michele, G. D., Gasser, T., Harhangi, B. S., Meco, G., Denèfle, P., Wood, N. W., et al. (2000) · New England Journal of Medicine · doi:10.1056/nejm200005253422103 · Cited by 1,489
Bilateral deep brain stimulation in Parkinson's disease: a multicentre study with 4 years follow-up.
Rodríguez-Oroz, M., Obeso, J., Lang, A., Houeto, J., Pollak, P., Rehncrona, S., Kulisevsky, J., Albanese, A., Volkmann, J., Hariz, M., et al. (2005) · Brain : a journal of neurology · doi:10.1093/brain/awh571 · Cited by 1,120
Multiple system atrophy: A review of 203 pathologically proven cases
Wenning, G. K., Tison, F., Ben‐Shlomo, Y., Daniel, S. E., & Quinn, N. P. (1997) · Movement Disorders · doi:10.1002/mds.870120203 · Cited by 802
Fahn, S. (1998) · Neurology · doi:10.1212/wnl.50.5_suppl_5.s1 · Cited by 738
Concept and classification of dystonia.
Fahn, S. (1988) · PubMed · Cited by 522
Young onset Parkinson's disease
Quinn, N. P., Critchley, P., & MARSDEN, C. D. (1987) · Movement Disorders · doi:10.1002/mds.870020201 · Cited by 450
Duodenal levodopa infusion monotherapy vs oral polypharmacy in advanced Parkinson disease
Nyholm, D., Remahl, A. I. M. N., Dizdar, N., Constantinescu, R., Holmberg, B., Jansson, R., Aquilonius, S. M., & Askmark, H. (2005) · Neurology · doi:10.1212/01.wnl.0000149637.70961.4c · Cited by 432
PARK7, a Novel Locus for Autosomal Recessive Early-Onset Parkinsonism, on Chromosome 1p36
van Duijn, C. M., Dekker, M. C. J., Bonifati, V., Galjaard, R. H., Houwing‐Duistermaat, J. J., Snijders, P. J. L. M., Testers, L., Breedveld, G. J., Horstink, M. W. I. M., Sandkuijl, L. A., et al. (2001) · The American Journal of Human Genetics · doi:10.1086/322996 · Cited by 385
A comparison of clinical and pathological features of young‐ and old‐onset Parkinson's disease
Gibb, W. R. G., & Lees, A. J. (1988) · Neurology · doi:10.1212/wnl.38.9.1402 · Cited by 371
Parkin disease: a phenotypic study of a large case series
Khan, N. L., Graham, E., Critchley, P., Schrag, A. E., Wood, N. W., Lees, A. J., Bhatia, K. P., & Quinn, N. P. (2003) · Brain · doi:10.1093/brain/awg142 · Cited by 352
Influence of mutation type and X chromosome inactivation on Rett syndrome phenotypes
Amir, R. E., den Veyver, I. B. V., Schultz, R., Malicki, D. M., Tran, C. Q., Dahle, E. J., Philippi, A., Tímár, L., Percy, A. K., Motil, K. J., et al. (2000) · Annals of Neurology · doi:10.1002/1531-8249(200005)47:5 · Cited by 351
Azher, S. N., & Jankovic, J. J. (2005) · Neurology · doi:10.1212/01.wnl.0000171857.09079.9f · Cited by 345
Encephalitis lethargica syndrome: 20 new cases and evidence of basal ganglia autoimmunity
Dale, R. C. (2003) · Brain · doi:10.1093/brain/awh008 · Cited by 343
Early-onset parkinsonism associated with PINK1 mutations
Bonifati, V., Rohé, C. F., Breedveld, G. J., Fabrizio, E., Mari, M. D., Tassorelli, C., Tavella, A., Marconi, R., Nicholl, D. J., Chien, H. F., et al. (2005) · Neurology · doi:10.1212/01.wnl.0000167546.39375.82 · Cited by 338
Zadikoff, C., & Lang, A. E. (2005) · Brain · doi:10.1093/brain/awh560 · Cited by 262
Krack, P. (1999) · Brain · doi:10.1093/brain/122.6.1133 · Cited by 230
Reed, C. D., & Tolley, J. (1967) · PubMed · Cited by 218
Young‐onset Parkinson's disease
Golbe, L. I. (1991) · Neurology · doi:10.1212/wnl.41.2_part_1.168 · Cited by 200
TURPENTINE AND THROMBOCYTOPENIC PURPURA
Wahlberg, P., & Nyman, D. (1969) · The Lancet · doi:10.1016/s0140-6736(69)91454-8 · Cited by 198
Tassin, J., Dürr, A., Bonnet, A.-M., Gil, R., Vidailhet, M., Lücking, C. B., Goas, J.-Y., Durif, F., Abada-Bendib, M., Échenne, B., et al. (2000) · Brain · doi:10.1093/brain/123.6.1112 · Cited by 191
HIGH-DOSE INTRAVENOUS GAMMABLOBULIN: A CAUTIONARY NOTE
Ljung, R., & Nilsson, I. (1985) · The Lancet · doi:10.1016/s0140-6736(85)91195-x · Cited by 176
Dystonia in multiple system atrophy
Boesch, S. (2002) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.72.3.300 · Cited by 168
Dystonia in parkinson's disease: Clinical and pharmacological features
Poewe, W. H., Lees, A. J., & Stern, G. M. (1988) · Annals of Neurology · doi:10.1002/ana.410230112 · Cited by 162
Mathers, S., Kempster, P. A., Swash, M., & Lees, A. J. (1988) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.51.12.1503 · Cited by 158
“Apraxia of lid opening,” a focal eyelid dystonia: Clinical study of 32 patients
Krack, P., & Marion, M.-H. (1994) · Movement Disorders · doi:10.1002/mds.870090605 · Cited by 149
Jankovic, J., & Tintner, R. (2001) · Parkinsonism & Related Disorders · doi:10.1016/s1353-8020(01)00025-6 · Cited by 135
Effect of subthalamic nucleus stimulation on levodopa-induced dyskinesia in Parkinson’s disease
Fraix, V., Pollak, P., Blercom, N. V., Xie, J., Krack, P., Koudsié, A., & Benabid, A. (2000) · Neurology · doi:10.1212/wnl.55.12.1921 · Cited by 132
Not paralysis, but dystonia causes stridor in multiple system atrophy
Merlo, I. M., Occhini, A., Pacchetti, C., & Alfonsi, E. (2002) · Neurology · doi:10.1212/wnl.58.4.649 · Cited by 130
Dystonia in progressive supranuclear palsy.
Barclay, C. L., & Lang, A. E. (1997) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.62.4.352 · Cited by 126
Richardson, J. C., Steele, J. C., & Olszewski, J. (1963) · PubMed · Cited by 125
Striatal deformities of the hand and foot in Parkinson's disease
Ashour, R. R., Tintner, R., & Jankovic, J. J. (2005) · The Lancet Neurology · doi:10.1016/s1474-4422(05)70119-8 · Cited by 120
Dystonia in Parkinson's disease, multiple system atrophy, and progressive supranuclear palsy
Rivest, J., Quinn, N. P., & MARSDEN, C. D. (1990) · Neurology · doi:10.1212/wnl.40.10.1571 · Cited by 108
Melamed, E. (1979) · Archives of Neurology · doi:10.1001/archneur.1979.00500410086014 · Cited by 105
LISURIDE INFUSION PUMP: A DEVICE FOR THE TREATMENT OF MOTOR FLUCTUATIONS IN PARKINSON'S DISEASE
Obeso, J. A., Luquín, M. R., & Martínez‐Lage, J. M. (1986) · The Lancet · doi:10.1016/s0140-6736(86)92929-6 · Cited by 98
Phenomenology of “Lubag” or X‐linked dystonia–parkinsonism
Evidente, V. G. H., Advincula, J. M., Esteban, R. P., Pasco, P. M. D., Alfon, J. A. R., Natividad, F. F., Cuanang, J. R., Luis, A. S., Gwinn, K. A., Hardy, J., et al. (2002) · Movement Disorders · doi:10.1002/mds.10271 · Cited by 94
The PINK1 phenotype can be indistinguishable from idiopathic Parkinson disease
Albanese, A., Valente, E. M., Romito, L. M., Bellacchio, E., Elia, A. E., & Dallapiccola, B. (2005) · Neurology · doi:10.1212/01.wnl.0000163999.72864.fd · Cited by 88
Forms of dystonia in patients with Parkinson's disease
Kidron, D., & Melamed, E. (1987) · Neurology · doi:10.1212/wnl.37.6.1009 · Cited by 87
Levodopa Infusion Therapy in Parkinson Disease
Nyholm, D., & Aquilonius, S. (2004) · Clinical Neuropharmacology · doi:10.1097/01.wnf.0000144041.28224.b7 · Cited by 66
Henderson, A., & Pearson, J. E. G. (1968) · The Lancet · doi:10.1016/s0140-6736(68)92082-5 · Cited by 64
Cabergoline in Parkinson's disease
Lera, G., Vaamonde, J., Rodriguez, M., & Obeso, J. A. (1993) · Neurology · doi:10.1212/wnl.43.12.2587 · Cited by 62
Lamberti, P., Mari, M. D., Zenzola, A., Aniello, M. S., & Defazio, G. (2002) · Neurological Sciences · doi:10.1007/s100720200080 · Cited by 57
Oerlemans, W. G. H., & de Visser, M. (1998) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.65.2.258 · Cited by 56
Dystonia in Untreated Parkinsonism
LeWitt, P. A., Burns, R. S., & Newman, R. P. (1986) · Clinical Neuropharmacology · doi:10.1097/00002826-198606000-00007 · Cited by 54
Camptocormia or Pisa syndrome in multiple system atrophy
Sławek, J. W., Derejko, M., Lass, P., & Dubaniewicz, M. (2005) · Clinical Neurology and Neurosurgery · doi:10.1016/j.clineuro.2005.07.004 · Cited by 52
Motor and non motor effects during intraoperative subthalamic stimulation for Parkinson?s disease
Sauleau, P., Raoul, S., Lallement, F., Rivier, I., Drapier, S., Lajat, Y., & Vérin, M. (2005) · Journal of Neurology · doi:10.1007/s00415-005-0675-5 · Cited by 49
Juvenile onset Parkinson's disease.
Gershanik, O. S., & Leist, A. (1987) · PubMed · Cited by 46
Camptocormia as a form of dystonia in Parkinson's disease
Sławek, J. W., Derejko, M., & Lass, P. (2003) · European Journal of Neurology · doi:10.1046/j.1468-1331.2003.00503_1.x · Cited by 44
Kinesigenic foot dystonia as a presenting feature of Parkinson's disease.
Lees, A. J., Hardie, R. J., & Stern, G. M. (1984) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.47.8.885 · Cited by 43
Normal dopamine transporter binding in dopa responsive dystonia
Huang, C., Yen, T., Weng, Y.-H., & Lu, C. (2002) · Journal of Neurology · doi:10.1007/s00415-002-0776-3 · Cited by 41
Limb dystonia in progressive supranuclear palsy
Rafal, R. D., & Friedman, J. H. (1987) · Neurology · doi:10.1212/wnl.37.9.1546 · Cited by 40
Parkinsonism following dystonia in three patients
Katchen, M., & Duvoisin, R. C. (1986) · Movement Disorders · doi:10.1002/mds.870010210 · Cited by 38
Levodopa-induced oromandibular dystonia in progressive supranuclear palsy
Tan, E. K., Chan, L. L., & Wong, M. C. (2003) · Clinical Neurology and Neurosurgery · doi:10.1016/s0303-8467(02)00128-2 · Cited by 36
SPECT imaging of the dopamine transporter in juvenile-onset dystonia
O’Sullivan, J. D., Costa, D. C., Gacinovic, S., & Lees, A. J. (2001) · Neurology · doi:10.1212/wnl.56.2.266 · Cited by 35
Parkinsonism and dystonia, pseudo-parkinsonism and pseudodystonia.
Quinn, N. P. (1993) · PubMed · Cited by 34
Oide, T., Ohara, S., Yazawa, M., Inoue, K., Itoh, N., Tokuda, T., & Ikeda, S. (2002) · Acta Neuropathologica · doi:10.1007/s00401-002-0531-y · Cited by 33
Stewart, P. (1898) · The Lancet · doi:10.1016/s0140-6736(01)84377-4 · Cited by 33
Hu, M. T. M., Bland, J. D. P., Clough, C., Ellis, C. M., & Chaudhuri, К. R. (1999) · Journal of Neurology · doi:10.1007/s004150050430 · Cited by 31
Controlled Release Levodopa-Carbidopa (CR-5) in the Management of Parkinsonian Motor Fluctuations
Juncos, J. L., Fabbrini, G., Mouradian, M. M., & Chase, T. N. (1987) · Archives of Neurology · doi:10.1001/archneur.1987.00520220016008 · Cited by 29
The Pharmacology of Foot Dystonia in Parkinsonism
Poewe, W. H., & Lees, A. J. (1987) · Clinical Neuropharmacology · doi:10.1097/00002826-198702000-00004 · Cited by 28
Klawans, H. L., & Paleologos, N. A. (1986) · Clinical Neuropharmacology · doi:10.1097/00002826-198606000-00008 · Cited by 28
Muñoz, J. E., Martı́, M. J., Marin, C. A., & TOLOSA, E. S. (1997) · Clinical Neuropharmacology · doi:10.1097/00002826-199706000-00009 · Cited by 26
Self-citationZwaveling‐Soonawala, N., Bhatia, K. P., Yeung, J. H. M., Quinn, N. P., & MARSDEN, C. D. (1999) · Journal of Neurology · doi:10.1007/s004150050347 · Cited by 24
LITHIUM FOR PAINFUL DYSTONIA IN PARKINSON'S DISEASE
Quinn, N. P., & MARSDEN, C. D. (1986) · The Lancet · doi:10.1016/s0140-6736(86)91681-8 · Cited by 24
Camptocormia in Idiopathic Parkinson’s Disease: [123I]β-CIT SPECT and Clinical Characteristics
Holler, I., Dirnberger, G., Pirker, W., Auff, E., & Gerschlager, W. (2003) · European Neurology · doi:10.1159/000072514 · Cited by 23
Dystonia in corticobasal degeneration.
Vanek, Z. F., & Jankovic, J. J. (2000) · PubMed · Cited by 20
Marked asymmetry of putaminal pathology in an MSA‐P patient with Pisa syndrome
Hozumi, I., Piao, Y.-S., Inuzuka, T., Matsuyama, Z., Yamada, Y., Hara, A., Hirose, T., Tsuchiya, K., & Takahashi, H. (2003) · Movement Disorders · doi:10.1002/mds.10668 · Cited by 20
Laryngeal dystonia causing upper airway obstruction in progressive supranuclear palsy
Panegyres, P. K., Hillman, D. R., & Dunne, J. W. (2006) · Journal of Clinical Neuroscience · doi:10.1016/j.jocn.2005.12.019 · Cited by 18
[Cabergoline in the treatment of Parkinson's disease].
Pástor, P., & TOLOSA, E. S. (2003) · PubMed · Cited by 16
Self-citationBROMOCRIPTINE IN TREATMENT OF LEVODOPA-INDUCED END-OF-DOSE DYSTONIA
Lees, A. J., & Stern, G. M. (1980) · The Lancet · doi:10.1016/s0140-6736(80)90111-7 · Cited by 11
Apraxia of Eyelid Opening After Bilateral Stereotaxic Subthalamotomy
Klostermann, W. E. M., Vieregge, P., & mpf, D. K. (1997) · Journal of Neuro-Ophthalmology · doi:10.1097/00041327-199706000-00009 · Cited by 8
Nakanishi, I., Hironishi, M., Miwa, H., & Kondo, T. (2003) · PubMed · Cited by 1
Louis (1999) · doi:10.1002/1531-8257(199905)14:3
Cited by
Sorted by citations
The clinical symptoms of Parkinson's disease.
Sveinbjornsdottir, S. (2016) · Journal of Neurochemistry · doi:10.1111/jnc.13691 · Cited by 1,410
“In medically treated PD, dystonia, along with dyskinesias, constitutes one of the main motor complications related to chronic therapy, usually occurring as an off-period phenomenon, but can present as peak dose dystonia or diphasic dystonia (Tolosa and Compta 2006).”
BackgroundInfluentialMaiti, P., Manna, J., & Dunbar, G. L. (2017) · Translational Neurodegeneration · doi:10.1186/s40035-017-0099-z · Cited by 557
“A variety of pain, aches, muscle spasms or dystonia have been observed in PD [33].”
BackgroundThe functional neuroanatomy of dystonia
Neychev, V. K., Gross, R. E., Lehéricy, S., Hess, E. J., & Jinnah, H. A. (2011) · Neurobiology of Disease · doi:10.1016/j.nbd.2011.01.026 · Cited by 473
“…in idiopathic Parkinson's disease and several Parkinson-plus syndromes (Jankovic and Tintner, 2001; Rivest et al., 1990; Schneider et al., 2009; Tolosa and Compta, 2006), where the primary pathology involves dysfunction of dopaminergic and other basal ganglia pathways (Perlmutter and Mink,…”
BackgroundSchwingenschuh, P., Ruge, D., Edwards, M. J., Terranova, C., Katschnig, P., Carrillo, F., Silveira‐Moriyama, L., Schneider, S. A., Kägi, G., Palomar, F. J., et al. (2010) · Movement Disorders · doi:10.1002/mds.23019 · Cited by 248
“It is however uncommon in untreated patients and is more frequently seen as a complication of its treatment (Tolosa and Compta, 2006).”
BackgroundHa, A. D., & Jankovic, J. J. (2011) · Movement Disorders · doi:10.1002/mds.23959 · Cited by 224
“More often, however, dystonia in PD occurs as a complication of treatment.(32) Levodopa-related dystonia may occur at various stages of the medication cycle.”
Background
Metadata
- Authors
- Tolosa, E., & Compta, Y.
- Affiliations
- Hospital Clínic de Barcelona (ES)
- Corresponding author
- Tolosa, Eduardo
- Venue
- Journal of Neurology
- Published
- 2006-12
- Volume
- 253
- Issue
- S7
- Pages
- vii7-vii13
- ISSN
- 0012-1037 (ISSN-L)
- 0340-5354
- 1432-1459
- OpenAlex
- W2068778836
- Cited by
- 176
- References
- 79
- Citations by year
- 2026: 3 · 2025: 8 · 2024: 10 · 2023: 7 · 2022: 14 · 2021: 13 · 2020: 7 · 2019: 13 · 2018: 12 · 2017: 8 · 2016: 12 · 2015: 9 · 2014: 7 · 2013: 5 · 2012: 8
- FWCI
- 0.80
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Journal of Neurology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Clinical Neurology › Deep Brain Stimulation and Movement Disorders
- Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
- Health Sciences › Medicine › Clinical Neurology › Botulinum Toxin and Related Neurological Disorders
- Keywords
- dystonia, Parkinson's disease, levodopa therapy, subthalamic nucleus, early-onset Parkinson's disease, camptocormia, anismus, blepharospasm, torticollis, progressive supranuclear palsy, multiple system atrophy, corticobasal degeneration, differential diagnosis
- MeSH terms
- Dystonia, Humans, Parkinson Disease
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review